article_metadata: Chenggong Li Yan Sun Jing Wang Lu Tang Huiwen Jiang Tao Guo Lin Liu Yaohui Wu Lisha Ai Linghui Xia Jianjun Wu Zhicai Lin Qijun Qian Yu Hu Heng Mei
article_metadata: 10.3389/fimmu.2021.599493
article_metadata: Front Immunol
article_metadata: 2021 May 25;12:599493.
article_metadata: piggybac transposon system chimeric antigen receptor-t cell therapy diffuse large b cell lymphoma lenalidomide maintenance relapsed/refractory triple-hit lymphoma
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/34113336/
article_metadata: Immunotherapy, Adoptive Lenalidomide / administration & dosage Lymphoma, Large B-Cell, Diffuse / therapy Remission Induction
article_metadata: Immunotherapy, Adoptive Lenalidomide / administration & dosage Lymphoma, Large B-Cell, Diffuse / therapy Remission Induction Case Reports Clinical Trial, Phase I Research Support, Non-U.S. Gov't Humans Lymphoma, Large B-Cell, Diffuse / immunology Lymphoma, Large B-Cell, Diffuse / pathology Male Middle Aged Recurrence Lenalidomide
article_metadata: PMC8186315
article_metadata: 34113336
article_metadata: PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report
article_metadata: 2021